Lilia Neuro

 

Category: Medical Devices

Exhibitor: DEPARTMENT OF SOCIAL WELFARE, TAIPEI CITY GOVERNMENT

Booth No: N402

 

Characteristic

 

Lilia Neuro is the world’s first home-use wearable device that integrates EEG monitoring, Cranial Electrotherapy Stimulation (CES), and AI-driven neurofeedback training. It offers a non-pharmaceutical approach to improving anxiety and insomnia through vagus nerve modulation and personalized neurofeedback.
Unlike traditional CES or clinical neurofeedback therapies, Lilia features real-time AI EEG analysis, enabling users to quantify and track their neural response. By embedding AI, it brings lab-grade neurotraining into daily life. An open SDK further allows integration with digital health platforms to expand its applications.
The device completed usability evaluation in late 2024, with final design, wearability testing, and AI model validation in Q2 2025. Human trials are planned for Q3 2025. Positioned as a next-generation mental wellness platform, Lilia holds strong market potential.

 

Other Products

 

• 

  Macroinsight Innovation-MacroPACS AI platform

• 

  ACT Genomics Co. Ltd-NGS Cancer Genomics Testing

• 

  GENETICS GENERATION ADVANCEMENT CORP. (GGA CORP.)-AI-powered Exosomal miRNA Precision Target Analysis Platform

• 

  TaiHao Medical Inc.-TaiHao Med AI Solution

• 

  AmCAD-UO、AmCAD-UT

• 

  AI-Powered Innovation: Designing the Next-Gen Degrader Therapeutics

• 

  Stress EEG Assessment System

• 

  V5med Lung AI

• 

  Nano CASTᵀᴹ Cancer Solution

 

 

 

Back